Corbus Pharmaceuticals Holdings, Inc.
Clinical-stage biopharma developing targeted therapies for oncology and obesity.
CRBP | US
Overview
Corporate Details
- ISIN(s):
- US21833P3010
- LEI:
- Country:
- United States of America
- Address:
- 500 RIVER RIDGE DRIVE, 2062 NORWOOD
- Website:
- https://www.corbuspharma.com/
- Sector:
- Manufacturing
Description
Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative treatments for oncology and obesity. The company's pipeline is centered on targeted therapies designed to address significant unmet medical needs and improve patient outcomes. Its lead oncology candidate, CRB-701, is an antibody-drug conjugate (ADC) in Phase 1/2 clinical development for treating solid tumors, including Head and Neck Squamous Cell Carcinoma (HNSCC) and cervical cancer. Corbus is committed to advancing its programs through rigorous scientific research and a focus on enhancing quality of life for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Corbus Pharmaceuticals Holdings, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Corbus Pharmaceuticals Holdings, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Corbus Pharmaceuticals Holdings, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
